Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Aug 5;10(15):e35491. doi: 10.1016/j.heliyon.2024.e35491

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 Published by Elsevier Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 2 — Network pharmacology analysis results. (A)Targets of NAFLD (B) Venn diagram of the 188 common targets between the active compounds' targets of Shugan Yipi Granule and the disease targets of NAFLD. (C) protein-protein interaction (PPI) network of Shugan Yipi Granule treating NAFLD. (D) Hub genes of Shugan Yipi Granule treating NAFLD. (E) Cluster analysis of the key targets. (F) GO analysis of candidate targets. GO enrichment analysis in metascape showed ten remarkably enriched items in BP, CC, and MF. (G) Significantly enriched information about the top 20 pathways of Shugan Yipi Granule in the treatment of NAFLD. (H) D-C-T-P-D network.